Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/431,145external-prioritypatent/US5731339A/en
Application filed by Zonagen IncfiledCriticalZonagen Inc
Publication of NZ335731ApublicationCriticalpatent/NZ335731A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicinal Preparation
(AREA)
Abstract
An orally administrable solution for improving the human sexual response comprising a vasodilator, wherein the solution is capable of delivering to the blood, an amount of vasodilator effective to increase blood flow to the genitalia within 1 hour of administration.
NZ335731A1995-04-281999-05-12Formulations for modulating the human sexual response comprising a vasodilator
NZ335731A
(en)
Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
THE USE OF 17 ß -(N-TERT-BUTYLCARBAMOYIL)-4-AZA-5-ALPHA-ANDROST-1-ENE-3-ONE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ANDROGENIC ALOPECIA